MILBY RANDY 4/A
4/A · Hillstream BioPharma Inc. · Filed Mar 13, 2023
Insider Transaction Report
Form 4/AAmended
MILBY RANDY
DirectorCEO
Transactions
- Award
Options (right to purchase)
2023-01-01+515,127→ 515,127 totalExercise: $0.39From: 2023-01-01Exp: 2033-01-01→ Common stock (515,127 underlying)
Footnotes (1)
- [F1]The options were issued pursuant to the Issuer's 2019 Stock Incentive Plan and vested in full upon grant.